Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Phillip Phiri"'
Autor:
Tiffany Woo, Kyo Sang Kim, Yon Hee Shim, Mi Kyeong Kim, Suk Min Yoon, Young Jin Lim, Hong Seuk Yang, Phillip Phiri, Jin Young Chon
Publikováno v:
Korean Journal of Anesthesiology, Vol 65, Iss 6, Pp 501-507 (2013)
BackgroundRapid and complete reversal of neuromuscular blockade (NMB) is desirable at the end of surgery. Sugammadex reverses rocuronium-induced NMB by encapsulation. It is well tolerated in Caucasian patients, providing rapid reversal of moderate (r
Externí odkaz:
https://doaj.org/article/bfafe46503464b08a8ac961efdc7c7c8
Publikováno v:
International Journal of Geriatric Psychiatry. 27:472-482
Objectives The aim of this study was to assess the short-term tolerability of two titration schedules of sublingual asenapine in older patients with psychosis, not associated with organic brain disease, and to compare asenapine pharmacokinetics in ol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebea6b0e45d5572f09a36bdcf545608f
https://doi.org/10.1002/gps.2737
https://doi.org/10.1002/gps.2737
Autor:
Michael, Sension, Jose Luiz de, Andrade Neto, Beatriz, Grinsztejn, Jean Michel, Molina, Isidro, Zavala, Juan, González-García, Alice, Donnelly, Phillip, Phiri, Emilio, Ledesma, Donnie, McGrath, Frederico, Rangel
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 51:153-162
The following members of the 067 Study Group participated in subject recruitment, enrollment, medical management, and data collection: William Powderly, MD, St. Louis, MO; Joseph Jemsek, MD, Huntersville, NC; Robert Eng, MD, East Orange, NJ; Dorece N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb286b047d4fba1f2f4c66ad20c27132
https://doi.org/10.1097/qai.0b013e3181a5701c
https://doi.org/10.1097/qai.0b013e3181a5701c
Autor:
Phillip Phiri, Mario G. Pessoa, Carlos Eduardo Brandão-Mello, Helena Brett-Smith, Brian Gazzard, Andrea Hall, Vicente Soriano, Anna K Huang, Maria Cassia Mendes-Correa, Isabel Cassetti
Publikováno v:
AIDS. 22:1779-1787
Background: Prolonged use of lamivudine in patients coinfected with HIV and hepatitis B virus (HBV) leads to an increasing risk of lamivudine resistance in both diseases. We investigated the addition of entecavir, a potent inhibitor of HBV polymerase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9532dbb15a453b7b76a93e86e718c2e7
https://doi.org/10.1097/qad.0b013e32830b3ab5
https://doi.org/10.1097/qad.0b013e32830b3ab5
Publikováno v:
Schizophrenia research. 150(2-3)
Background A Phase 2 efficacy study suggested that asenapine (ASE) was superior to risperidone in decreasing negative symptoms in schizophrenia at 6 weeks, prompting design of two negative symptom studies. Two 26-week core studies with 26-week extens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab4193aeffab37079533c5c800b4d67
https://pubmed.ncbi.nlm.nih.gov/24075603
https://pubmed.ncbi.nlm.nih.gov/24075603
Autor:
Phillip Phiri, Mi Kyeong Kim, Suk Min Yoon, Young Jin Lim, Tiffany Woo, Kyo Sang Kim, Yon Hee Shim, Hong Seuk Yang, Jin Young Chon
Publikováno v:
Korean Journal of Anesthesiology
Korean Journal of Anesthesiology, Vol 65, Iss 6, Pp 501-507 (2013)
Korean Journal of Anesthesiology, Vol 65, Iss 6, Pp 501-507 (2013)
Background: Rapid and complete reversal of neuromuscular blockade (NMB) is desirable at the end of surgery. Sugammadex reverses rocuronium-induced NMB by encapsulation. It is well tolerated in Caucasian patients, providing rapid reversal of moderate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f42fffbc0f6ac35d873dbf9c1a6172
https://pubmed.ncbi.nlm.nih.gov/24427455
https://pubmed.ncbi.nlm.nih.gov/24427455
Publikováno v:
Encyclopedia of Biopharmaceutical Statistics ISBN: 1439822468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765262c5eb87dde1abbf1152f84fa42c
https://doi.org/10.1201/b14674-135
https://doi.org/10.1201/b14674-135
Autor:
Robert W. Buchanan, Nina Schooler, Larry Alphs, Armin Szegedi, Wil den Hollander, Phillip Phiri, Alex Kouassi, Xianwei Ha, John Panagides, Jun Zhao, Pilar Cazorla
Publikováno v:
Journal of clinical psychopharmacology. 32(1)
Two randomized, double-blind, 26-week core studies (Eastern [EH] and Western Hemisphere [WH]) tested the hypothesis that asenapine is superior to olanzapine for persistent negative symptoms of schizophrenia; 26-week extension studies assessed the com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd369809ed0eb1803e44eae17b35ec8
https://pubmed.ncbi.nlm.nih.gov/22198451
https://pubmed.ncbi.nlm.nih.gov/22198451
Publikováno v:
International journal of geriatric psychiatry. 27(5)
The aim of this study was to assess the short-term tolerability of two titration schedules of sublingual asenapine in older patients with psychosis, not associated with organic brain disease, and to compare asenapine pharmacokinetics in older patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed3a2416b6e4f9e86462a4ae486f6b4e
https://pubmed.ncbi.nlm.nih.gov/21755540
https://pubmed.ncbi.nlm.nih.gov/21755540
Publikováno v:
Schizophrenia Research. 117:263-264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91ea97298b1a6764c77a909153d2c226
https://doi.org/10.1016/j.schres.2010.02.417
https://doi.org/10.1016/j.schres.2010.02.417